[This corrects the article DOI: 10.1155/2017/8370593.].
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8112953 | PMC |
| http://dx.doi.org/10.1155/2021/9812928 | DOI Listing |
Publication Analysis
Top Keywords
corrigendum "myricetin
4
"myricetin possesses
4
possesses potential
4
potential protective
4
protective effects
4
effects diabetic
4
diabetic cardiomyopathy
4
cardiomyopathy inhibiting
4
inhibiting ib/nfb
4
ib/nfb enhancing
4
Similar Publications
Corrigendum: Myricetin suppresses TGF-β-induced epithelial-to-mesenchymal transition in ovarian cancer.
Front Pharmacol
November 2024
Xuzhou Key Laboratory of Laboratory Diagnostics, Xuzhou Medical University, Xuzhou, Jiangsu, China.
[This corrects the article DOI: 10.3389/fphar.2023.
View Article and Find Full Text PDFCorrigendum to "Myricetin Possesses Potential Protective Effects on Diabetic Cardiomyopathy through Inhibiting IB/NFB and Enhancing Nrf2/HO-1".
Oxid Med Cell Longev
May 2021
Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China.
[This corrects the article DOI: 10.1155/2017/8370593.].
View Article and Find Full Text PDFCorrigendum to "Myricetin inhibits TNF-α-induced inflammation in A549 cells via the SIRT1/NF-κB pathway" [Pulm. Pharmacol. Therapeut. 65 (2020) 102000].
Pulm Pharmacol Ther
June 2021
Institute of Respiratory Diseases, Department of Respiratory and Critical Care Medicine, The Affiliated Hospital of Guangdong Medical University, Zhanjiang, 524001, China. Electronic address:
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!